Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
about
Mechanism of Anti-α-Synuclein ImmunotherapyAdult Astrogenesis and the Etiology of Cortical NeurodegenerationDisease-modifying therapeutic directions for Lewy-Body dementiasIntegration of multiscale dendritic spine structure and function data into systems biology modelsAlpha-synuclein biology in Lewy body diseasesThe contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierHigh-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates.Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathyProposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTP.Lewy body dementias.The role of Galectin-3 in α-synuclein-induced microglial activation.Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.Novel therapeutic approaches in multiple system atrophyHypothesis: somatic mosaicism and Parkinson diseaseATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation.Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages.Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregatesElevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysisAntagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.Structural and functional properties of prefibrillar α-synuclein oligomersIdentification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.Interactions between calcium and alpha-synuclein in neurodegeneration.Models of α-synuclein aggregation in Parkinson's disease.Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like PropagationNeuropathology of α-synuclein propagation and braak hypothesis.P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells.
P2860
Q26772943-CEC97354-67D8-40D0-A918-404E91C44B59Q26777109-F914F16D-2C06-4312-B3D9-2607BC5E14E7Q26782907-C9B0B9E2-DD01-4360-B746-B5555216CFE2Q27003132-92906791-67EF-41DB-A4A5-9EE6F08D25DEQ27003541-6ECA8521-CB5C-4C81-A5B5-010D449FB67AQ28068464-90C707EF-8457-4554-AAAD-EF27B5F1798DQ28071873-E29FFCD6-559D-46E4-9F5C-C7EAD27C590CQ30764286-FBB907BC-CC20-49C9-A5F1-CFC886A3C44DQ33735667-14785833-24F4-4B31-B7D1-DFD8030B49ACQ33868678-1C0C2963-7125-4F2C-8AEC-4CCE8EB86F56Q34241599-01D3D9EF-F3F1-4B02-9CCD-31F4BBDEB5D2Q34502646-2EABECE3-C870-46D9-9248-8C8924EB8BB2Q34537231-53430093-5A71-4338-85FA-27FAD61884F1Q34688885-1D45DC4C-C51C-4017-930C-0DE1B2BC2169Q34696470-D00EE37D-CF15-408B-A21E-9CC4EDC46754Q34774314-1C69EB91-AE06-40F9-B569-5BD195D6C27FQ34774337-0A3D30E8-8280-41BE-8559-B611684146B0Q35484552-3CCDD76C-1259-42A8-8231-8F6031B37BDBQ35547344-D33D5F87-4841-4F86-84E9-BC6D04F02DE7Q35574641-697F28B2-0EA9-49DC-B024-24DBC1C389C0Q35643171-186CAB68-09B9-425E-8FF0-F075C50705D2Q35659990-EFBBC81B-A321-4E64-9CAF-6E3F34571CDEQ35674483-C0A4006B-EA66-40BF-8C1C-EDC5519C1633Q35702700-B6C814AA-1707-4E39-8978-1D8D305BAF46Q35969183-3124A7C7-BA0C-41BA-AC79-6143C686B005Q36246469-6799BB43-B15F-4E85-B5E0-AB44B0375B33Q36284241-FC61B41C-944D-44E6-89BA-F45A9F4734C3Q36577891-0373A507-0A48-4249-8972-049AFC41ABDDQ36722186-51CEE3EB-E0D7-4647-83B5-6F46E0D54B1FQ36751579-E2A0E73A-EA95-46AA-B07A-DFCCED4A81E4Q36766239-804EB3D9-E8EE-4FE5-812F-D9EAF3B33D09Q36796130-34FBB8FA-4CFE-42B5-B0FE-360FBD370B04Q37024615-647EF37F-092F-40CF-B7F6-04DD06B69511Q38238302-485D162D-7B8A-42FF-A76C-0FE7518D0D0EQ38248883-4A19BBFA-B56B-45B8-B01C-28ACE17D0E83Q38254376-D69FD7FB-AA6D-4A47-B568-26F2B6E9A4B7Q38286574-837EE3FF-6467-46B8-BFC7-A5586B92BB0BQ38303579-4FBC5EA4-9307-4D7B-8D25-5A3155965976Q38580816-65DEF171-CABE-4C55-9B36-5F507F90599FQ38703135-31A994C2-4B4A-4953-BC74-266514BE249E
P2860
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
@en
type
label
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
@en
prefLabel
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.
@en
P2860
P1476
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases
@en
P2093
He-Jin Lee
Seung-Jae Lee
P2860
P2888
P356
10.1038/NRNEUROL.2013.275
P407
P50
P577
2014-01-28T00:00:00Z
P6179
1029402920